General Information and Variability Data of DT
DT ID DTD0001
Gene Name ABCC1
Protein Name Multidrug resistance-associated protein 1
Synonyms ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1
Gene ID
4363
UniProt ID
P33527
TCDB ID
3.A.1.208.8
DT Family ATP-Binding Cassette (ABC) Superfamily
Drug Conjugate Transporter (DCT) Family (ABCC)
Tissue Specificity High expressed in testis, cardiomyocytes, placenta, prostate, lung, thymus, and kidney, lower expression in small intestine, colon, brain, and mononuclear cells
Function This transporter mediates export of organic anions and drugs from the cytoplasm. Mediates ATP-dependent transport of glutathione and glutathione conjugates, leukotriene C4, estradiol-17-beta-o-glucuronide, methotrexate, antiviral drugs and other xenobiotics. Confers resistance to anticancer drugs. Hydrolyzes ATP with low efficiency.
Disease(s) Acute myeloid leukemia [ICD-11: 2A60]
High blood pressure [ICD-11: BA00]
Human immunodeficiency virus infection [ICD-11: 1C62.Z]
Strongyloidiasis due to nematode parasite [ICD-11: 1F6B]
Kaposi's sarcoma [ICD-11: 2B57]
Ovarian cancer [ICD-11: 2C73]
Type 2 diabetes [ICD-11: 5A11]
Seizures following neurosurgery [ICD-11: 8A6Z]
Urticaria [ICD-11: EB00-EB0Y]
Node-positive breast cancer [ICD-11: 2C60-2C6Z]
Genetic Polymorphisms & Epigenetic Regulations of DT
Species-, Tissue- and Disease-specific Protein Abundances of DT
Exogenous Factor Altering DT Activity
Approved Drug(s) Transported by This DT 99mTc-sestamibi Drug Info Breast cancer [ICD-11: 2C60-2C6Z] Approved [1]
Adefovir Drug Info Herpes simplex virus infection [ICD-11: 1F00] Approved [2]
Cefadroxil Drug Info Gram-positive & negative bacteria infections [ICD-11: 1A00-1H0Z] Approved [3]
Chlorpheniramine Drug Info Urticaria [ICD-11: EB00-EB0Y] Approved [4]
Cisplatin Drug Info Testicular cancer [ICD-11: 2C80] Approved [5]
Citalopram Drug Info Depression [ICD-11: 6A8Z] Approved [6]
Colchicine Drug Info Acute gouty arthritis [ICD-11: FA25] Approved [7]
Dactinomycin Drug Info Cancer [ICD-11: 2A00-2F9Z] Approved [8]
Daunorubicin Drug Info Acute myeloid leukemia [ICD-11: 2A60] Approved [9]
Dehydroepiandrosterone sulfate Drug Info Dyspareunia [ICD-11: GA12] Approved [10]
Docetaxel Drug Info Lung cancer [ICD-11: 2C25] Approved [2]
Doxorubicin Drug Info Leukemia [ICD-11: 2A60-2B33] Approved [11]
Epirubicin Drug Info Node-positive breast cancer [ICD-11: 2C60-2C6Z] Approved [12]
Estrone sulfate Drug Info Menopausal symptoms [ICD-11: MF32] Approved [13]
Ethacrynic acid Drug Info High blood pressure [ICD-11: BA00] Approved [14]
Etoposide Drug Info Testicular cancer [ICD-11: 2C80] Approved [15]
Fluorescein Drug Info Ocular disease [ICD-11: 9E1Z] Approved [16]
Flutamide Drug Info Prostate cancer [ICD-11: 2C82] Approved [17]
Folic acid Drug Info Vitamin deficiency [ICD-11: 5B55-5B7Z] Approved [18]
Glutathione Drug Info Human immunodeficiency virus infection [ICD-11: 1C62.Z] Approved [19]
Grepafloxacin Drug Info Chronic bronchitis [ICD-11: CA20.1] Approved [20]
Idarubicin Drug Info Acute myeloid leukemia [ICD-11: 2A60] Approved [2]
Indinavir Drug Info Human immunodeficiency virus infection [ICD-11: 1C62.Z] Approved [2]
Irinotecan Drug Info Colorectal cancer [ICD-11: 2B91] Approved [21]
Ivermectin Drug Info Strongyloidiasis due to nematode parasite [ICD-11: 1F6B] Approved [22]
Lopinavir Drug Info Human immunodeficiency virus infection [ICD-11: 1C62.Z] Approved [23]
Methotrexate Drug Info Leukemia [ICD-11: 2A60-2B33] Approved [24]
Mitoxantrone Drug Info Metastatic breast cancer [ICD-11: 2C6Y] Approved [25]
Paclitaxel Drug Info Breast cancer [ICD-11: 2C60-2C6Z] Approved [2]
Phenytoin Drug Info Seizures following neurosurgery [ICD-11: 8A6Z] Approved [26]
Quercetin Drug Info Coronary artery disease [ICD-11: BA6Z] Approved [2]
Saquinavir Drug Info Human immunodeficiency virus infection [ICD-11: 1C62.Z] Approved [27]
Saxagliptin Drug Info Type 2 diabetes [ICD-11: 5A11] Approved [28]
Topotecan Drug Info Ovarian cancer [ICD-11: 2C73] Approved [2]
Verapamil Drug Info High blood pressure [ICD-11: BA00] Approved [2]
Vinblastine Drug Info Testicular cancer [ICD-11: 2C80] Approved [29]
Vincristine Drug Info Acute lymphoblastic leukemia [ICD-11: 2B33.0] Approved [30]
Zoledronic acid Drug Info Paget's disease [ICD-11: FB85] Approved [31]
Clinical Trial Drug(s) Transported by This DT Phenethyl isothiocyanate Drug Info Cancer [ICD-11: 2A00-2F9Z] Phase 3 [2]
Glutathione-S-S-glutathione Drug Info Ovarian cancer [ICD-11: 2C73] Phase 2 [32]
SN-38 Drug Info Colon cancer [ICD-11: 2B90.Z] Phase 2 [21]
Chlorcyclizine Drug Info Hepatitis C virus infection [ICD-11: 1E50.2, 1E51.1] Phase 1 [4]
Withdrawn, Discontinued or Preclinical Drug(s) Transported by This DT Aminohippuric acid Drug Info Renal function tests [ICD-11: MG02] Withdrawn [33]
Resveratrol Drug Info Colorectal cancer [ICD-11: 2B91] Discontinued in Phase 2 [2]
Leukotriene E4 Drug Info Asthma [ICD-11: CA23] Preclinical [34]
Endogenous Substrate(s) Antimonial oxyanions; Antimony; Arsenic oxyanions; Arsenic triglutathione; Glutathione conjugates; Mercuric ions; Arsenate; Glucuronide-X; Aflatoxin B1-glutathione; Cobalamine; Leukotriene C4
Endogenous Metabolites (EMs) Handled by This DT Guanidine EM Info Identified using MATE1-overexpressing HEK293 cells [35]
Drug-DT Affinity Assessed by Cell Line
Drug(s) with Drug-DT Affinity Data Aminohippuric acid Drug Info Human cervical cancer cell line (Hela)-MRP1 Km = 372 microM [33]
Cefadroxil Drug Info Human embryonic kidney cells (HEK293)-MRP1 Km = 3.9 microM [3]
Citalopram Drug Info Human embryonic kidney cells (HEK293)-MRP1 Km = 1.99 microM [6]
Daunorubicin Drug Info Human small cell lung cancer cells Km = 1.4 microM [36]
Epirubicin Drug Info Human cervical cancer cell line (Hela)-MRP1 Km = 0.097 microM [12]
Estradiol-17beta-glucuronide Drug Info Human cervical cancer cell line (Hela)-MRP1 Km = 1.5 microM [34]
Estradiol-17beta-glucuronide Drug Info Human cervical cancer cell line (Hela)-MRP1 Km = 2.5 microM [37]
Estradiol-17beta-glucuronide Drug Info Human embryonic kidney cells (HEK293)-MRP1 Km = 1.5 microM [38]
Estrone sulfate Drug Info Human cervical cancer cell line (Hela)-MRP1 Km = 0.73 microM [39]
Estrone sulfate Drug Info Human cervical cancer cell line (Hela)-MRP1 Km = 2.1 microM [39]
Estrone sulfate Drug Info Human embryonic kidney cells (HEK293)-MRP1 Km = 4.2 microM [13]
Fluo-3 Drug Info Human cervical cancer cell line (Hela)-MRP1 Km = 12 microM [40]
Glutathione Drug Info Human cervical cancer cell line (Hela)-MRP1 Km = 5000 microM [41]
Methotrexate Drug Info Breast carcinoma cell line (MCF7)-MRP1 Km = 930 microM [42]
Methotrexate Drug Info Human embryonic kidney cells (HEK293)-MRP1 Km = 2150 microM [24]
Methotrexate Drug Info NIH3T3-MRP1 Km = 2150 microM [24]
References
1 99mTc-sestamibi is a substrate for P-glycoprotein and the multidrug resistance-associated protein. Br J Cancer. 1998;77(3):353-8.
2 Human intestinal transporter database: QSAR modeling and virtual profiling of drug uptake, efflux and interactions. Pharm Res. 2013 Apr;30(4):996-1007.
3 Oral availability of cefadroxil depends on ABCC3 and ABCC4. Drug Metab Dispos. 2012 Mar;40(3):515-21.
4 Carrier mediated transport of chlorpheniramine and chlorcyclizine across bovine olfactory mucosa: implications on nose-to-brain transport. J Pharm Sci. 2005 Mar;94(3):613-24.
5 Hammerhead ribozyme against gamma-glutamylcysteine synthetase sensitizes human colonic cancer cells to cisplatin by down-regulating both the glutathione synthesis and the expression of multidrug resistance proteins. Cancer Gene Ther. 2001 Oct;8(10):803-14.
6 MRP1 polymorphisms associated with citalopram response in patients with major depression. J Clin Psychopharmacol. 2010 Apr;30(2):116-25.
7 Pharmacological characterization of the murine and human orthologs of multidrug-resistance protein in transfected human embryonic kidney cells. Mol Pharmacol. 1997 Sep;52(3):344-53.
8 Expression of multidrug resistance-associated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution. Cancer Res. 1995 Nov 15;55(22):5342-7.
9 Vinblastine and sulfinpyrazone export by the multidrug resistance protein MRP2 is associated with glutathione export. Br J Cancer. 2000 Aug;83(3):375-83.
10 Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4). Biochem J. 2003 Apr 15;371(Pt 2):361-7.
11 The role of bioreductive activation of doxorubicin in cytotoxic activity against leukaemia HL60-sensitive cell line and its multidrug-resistant sublines. Br J Cancer. 2005 Jul 11;93(1):89-97.
12 Sulindac sulfide selectively increases sensitivity of ABCC1 expressing tumor cells to doxorubicin and glutathione depletion. J Biomed Res. 2016 Mar;30(2):120-133.
13 Molecular cloning and pharmacological characterization of rat multidrug resistance protein 1 (mrp1). Drug Metab Dispos. 2003 Aug;31(8):1016-26.
14 Inhibition of the multidrug resistance protein 1 (MRP1) by peptidomimetic glutathione-conjugate analogs. Mol Pharmacol. 2002 Nov;62(5):1160-6.
15 Multidrug resistance-associated protein-1 functional activity in Calu-3 cells. J Pharmacol Exp Ther. 2001 Sep;298(3):1199-205.
16 Transport of fluorescein in MDCKII-MRP1 transfected cells and mrp1-knockout mice. Biochem Biophys Res Commun. 2001 Jun 22;284(4):863-9.
17 The multidrug resistance-associated protein 1 transports methoxychlor and protects the seminiferous epithelium from injury. Toxicol Lett. 2003 Apr 30;142(1-2):61-70.
18 Folate concentration dependent transport activity of the Multidrug Resistance Protein 1 (ABCC1). Biochem Pharmacol. 2004 Apr 15;67(8):1541-8.
19 Structural determinants of substrate specificity differences between human multidrug resistance protein (MRP) 1 (ABCC1) and MRP3 (ABCC3). Drug Metab Dispos. 2008 Dec;36(12):2571-81.
20 Limited distribution of new quinolone antibacterial agents into brain caused by multiple efflux transporters at the blood-brain barrier. J Pharmacol Exp Ther. 2000 Oct;295(1):146-52.
21 ATP-Dependent efflux of CPT-11 and SN-38 by the multidrug resistance protein (MRP) and its inhibition by PAK-104P. Mol Pharmacol. 1999 May;55(5):921-8.
22 Interaction of ivermectin with multidrug resistance proteins (MRP1, 2 and 3). Chem Biol Interact. 2006 Feb 25;159(3):169-79.
23 Inhibition of P-glycoprotein and multidrug resistance-associated proteins modulates the intracellular concentration of lopinavir in cultured CD4 T cells and primary human lymphocytes. J Antimicrob Chemother. 2007 Nov;60(5):987-93.
24 Transport of methotrexate (MTX) and folates by multidrug resistance protein (MRP) 3 and MRP1: effect of polyglutamylation on MTX transport. Cancer Res. 2001 Oct 1;61(19):7225-32.
25 Multidrug resistance protein 1 (MRP1, ABCC1) mediates resistance to mitoxantrone via glutathione-dependent drug efflux. Mol Pharmacol. 2006 Apr;69(4):1499-505.
26 Evaluation of transport of common antiepileptic drugs by human multidrug resistance-associated proteins (MRP1, 2 and 5) that are overexpressed in pharmacoresistant epilepsy. Neuropharmacology. 2010 Jun;58(7):1019-32.
27 Direct evidence that saquinavir is transported by multidrug resistance-associated protein (MRP1) and canalicular multispecific organic anion transporter (MRP2). Antimicrob Agents Chemother. 2002 Nov;46(11):3456-62.
28 Dipeptidylpeptidase-4 inhibitors (gliptins): focus on drug-drug interactions. Clin Pharmacokinet. 2010 Sep;49(9):573-88.
29 Development and characterization of a recombinant Madin-Darby canine kidney cell line that expresses rat multidrug resistance-associated protein 1 (rMRP1). AAPS PharmSci. 2004 Mar 9;6(1):E8.
30 Interaction of plant cannabinoids with the multidrug transporter ABCC1 (MRP1). Eur J Pharmacol. 2008 Sep 4;591(1-3):128-31.
31 Zoledronic acid is synergic with vinblastine to induce apoptosis in a multidrug resistance protein-1 dependent way: an in vitro study. Cell Biol Int. 2006 Mar;30(3):278-82.
32 Anthracyclines modulate multidrug resistance protein (MRP) mediated organic anion transport. Biochim Biophys Acta. 1997 May 22;1326(1):12-22.
33 ATP-dependent para-aminohippurate transport by apical multidrug resistance protein MRP2. Kidney Int. 2000 Apr;57(4):1636-42.
34 Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. Cancer Res. 1996 Mar 1;56(5):988-94.
35 Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions/H(+)-organic cation antiporters. Biochem Pharmacol. 2007 Jul 15;74(2):359-71.
36 Competitive inhibition by genistein and ATP dependence of daunorubicin transport in intact MRP overexpressing human small cell lung cancer cells. Biochem Pharmacol. 1994 Sep 15;48(6):1129-36.
37 ATP-dependent 17 beta-estradiol 17-(beta-D-glucuronide) transport by multidrug resistance protein (MRP). Inhibition by cholestatic steroids. J Biol Chem. 1996 Apr 19;271(16):9683-9.
38 Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells. Mol Pharmacol. 1999 May;55(5):929-37.
39 Glutathione stimulates sulfated estrogen transport by multidrug resistance protein 1. J Biol Chem. 2001 Mar 2;276(9):6404-11.
40 Export pumps for anionic conjugates encoded by MRP genes. Adv Enzyme Regul. 1999;39:237-46.
41 Topological polar surface area defines substrate transport by multidrug resistance associated protein 1 (MRP1/ABCC1). J Med Chem. 2009 Feb 26;52(4):1214-8.
42 Multidrug resistance protein (MRP) 1 and MRP3 attenuate cytotoxic and transactivating effects of the cyclopentenone prostaglandin, 15-deoxy-Delta(12,14)prostaglandin J2 in MCF7 breast cancer cells. Biochemistry. 2003 May 13;42(18):5429-37.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.